pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    risvodetinib succinate
    risvodetinib succinate
    Parkinson's Disease Abli Therapeutics Inc
  • Preclinical
    ritanserin
    ritanserin
    Glioblastoma Multiforme (GBM) University of Virginia
  • Marketed
    ritlecitinib
    Litfulo (ritlecitinib [INN])
    Alopecia Areata$PFE PFIZER INC
  • Marketed
← prev
page 214 of 231
next →
Pain89
Neurology1
ritonavir
Ritonavir
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Quagen Pharmaceuticals LLC
  • Marketed
    rituximab
    Rituxan (rituximab)
    B-Cell Leukemia Genentech Inc
  • pre_registration
    rituximab biosimilar
    Riabni (rituximab-arrx)
    Unspecified Cancer Dr. Reddy's Laboratories Ltd
  • Phase 2
    rivasterat
    rivasterat [INN]
    Diabetic Macular Edema Thea Open Innovation SASU
  • Phase 3
    rivunatpagene miziparvovec
    rivunatpagene miziparvovec
    Wilson Disease$RARE Ultragenyx Pharmaceutical Inc.
  • Marketed
    rizatriptan benzoate ODT
    Rizatriptan Benzoate
    Migraine Bionpharma Inc
  • Phase 1
    riztunitide
    riztunitide
    Amyotrophic Lateral Sclerosis Neurodegenerative Disease Research Inc
  • Phase 2
    rocavorexant
    rocavorexant
    Opium (Opioid) Addiction$INDV Indivior Pharmaceuticals, Inc.
  • Preclinical
    rofecoxib
    Releven (rofecoxib)
    Osteoarthritis Pain BriOri BioTech Inc
  • Phase 2
    roginolisib
    roginolisib [INN]
    Metastatic Uveal Melanoma iOnctura SA
  • Phase 2
    rogocekib
    rogocekib [INN]
    Chronic Myelomonocytic Leukemia (CMML) Chordia Therapeutics Inc
  • Marketed
    rolapitant hydrochloride
    Varubi (rolapitant hydrochloride)
    Chemotherapy Induced Nausea and Vomiting TerSera Therapeutics LLC
  • Marketed
    romidepsin
    Romidepsin
    Cutaneous T-Cell Lymphoma Fresenius Kabi USA LLC
  • Phase 3
    romiplostim
    Nplate (romiplostim)
    Thrombocytopenia$AMGN AMGEN INC
  • Phase 3
    romosozumab
    Evenity (romosozumab-aqqg)
    Osteogenesis Imperfecta$AMGN AMGEN INC
  • Phase 2
    rondaptivon pegol
    rondaptivon pegol
    Hemophilia A (Factor VIII Deficiency) Band Therapeutics LLC
  • Phase 2
    rondecabtagene autoleucel
    rondecabtagene autoleucel [INN]
    Diffuse Large B-Cell Lymphoma$LYEL Lyell Immunopharma, Inc.
  • Phase 2
    ropanicant
    ropanicant [INN]
    Major Depressive Disorder Suven Life Sciences Ltd
  • pre_registration
    ropeginterferon alfa-2b LA
    Besremi (ropeginterferon alfa-2b [INN])
    Essential Thrombocythemia PharmaEssentia Corp
  • Phase 2
    rose bengal sodium
    rose bengal sodium [INN]
    Metastatic Melanoma$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
  • Phase 2
    rosolutamide
    rosolutamide [INN]
    Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) Annji Pharmaceutical Co Ltd
  • Phase 2
    rosopatamab tetraxetan
    rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Convergent Therapeutics Inc
  • Phase 3
    rostaporfin
    rostaporfin
    Metastatic Breast Cancer TuHURA Biosciences Inc
  • Marketed
    rosuvastatin calcium
    Rosuvastatin Calcium
    Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Teva Pharmaceuticals USA Inc
  • pre_registration
    rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine
    Rotarix
    Rotavirus Infections$GSK GSK plc
  • Marketed
    rotavirus [serotypes G1, G2, G3, G4, P1] (pentavalent) vaccine
    RotaTeq
    Rotavirus Infections$MRK Merck & Co., Inc.
  • Marketed
    rotigotine ER
    Neupro (rotigotine)
    Parkinson's Disease UCB SA